Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Is migraine an inflammatory event? Which inflammatory markers can we use for migraine?

Buket Tugan Yildiz, Tulay Tuba Koca.




Abstract
Cited by 2 Articles

Aim: It is considered that a relationship exist between migraine and neurogenic inflammation. High levels of tumor necrosis factor, interleukin-6 and C-reactive protein were determined in the studies. The cytoprotective and antioxidant effect of bilirubin has been shown. Lower serum bilirubin levels have been shown some diseases. For all that, there is no consensus in the results. Our purpose in this study is to determine the relationship between migraine and inflammation markers like erythrocyte sedimentation rate, C-reactive protein , bilirubin.
Material and Methods: The study included 50 migraine patients and 40 healthy individuals as a control group. Erythrocyte sedimentation rate and C-reactive protein, bilirubin parameters, aspartate aminotransferase, alanine aminotransferase were recorded.
Results: Erythrocyte sedimentation rate and C-reactive protein were significantly higher in migraine group. Bilirubin parameters and aspartate aminotransferase , alanine aminotransferase values were similar.
Conclusion: Higher serum inflammatory markers support the role of inflammation in migraine pathogenesis. For bilirubin levels larger cross- sectional studies are needed.

Key words: Migraine; Inflammation; C-reactive protein; Erythrocyte Sedimentation Rate.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.